# Nicotinamide Riboside (NR)

> Nicotinamide Riboside (NR) is a specialized form of vitamin B3 that raises cellular NAD+ for energy and DNA repair. It directly suppresses mast cell degranulation via SIRT6 and inhibits MMP enzymes that degrade collagen in hEDS. ZebraThrive uses 500 mg daily of generic NR chloride with COA verification, chosen over NMN to avoid the 87% NMN counterfeit rate.

**Page:** https://www.wellnessforzebras.com/ingredients/nicotinamide-riboside
**Brand:** ZebraThrive
**Author:** Ken Chapman, Founder of ZebraThrive
**Last reviewed:** 2026-05-11
**Daily dose:** 500 mg daily (250 mg BID)
**Form used:** Generic NR chloride (≥99% purity, COA-verified)
**Target population:** Adults 18+ with hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), or Mast Cell Activation Syndrome (MCAS).
**Regulatory framing:** US DSHEA dietary supplement. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

## Key benefits

- Elevates blood NAD+ by 40-60%
- Suppresses histamine, tryptase, and leukotrienes via SIRT6
- Inhibits MMP-9 upregulation in collagen tissues
- Restores mitochondrial function in vascular EDS models

## What it is

A specialized form of vitamin B3 that efficiently raises NAD+ levels, essential for cellular energy and repair.

## Why we include it

NR directly suppresses mast cell degranulation via the SIRT6 pathway and protects collagen by inhibiting MMP enzymes and upregulating crosslinking proteins.

## Plain-language summary

Nicotinamide Riboside (NR) is a form of vitamin B3 that your body converts to NAD+ - the molecule every cell uses for energy production and DNA repair. NAD+ levels fall with age and during chronic illness, and NR is one of the few precursors with solid human evidence for raising blood NAD+. The MCAS connection comes from a 2022 study showing NR suppresses mast cell degranulation through SIRT6 - an enzyme that depends directly on NAD+. We include NR because it raises NAD+ more reliably than its alternatives, and because the mast cell mechanism work has held up across both mouse and human cell studies.

## Mechanism

Nicotinamide Riboside (NR) is a cellular fuel that activates protective proteins called sirtuins.

For mast cells (MCAS): Groundbreaking 2022 research found that NR directly suppresses mast cell degranulation through the SIRT6 pathway. This reduces the release of histamine, tryptase, prostaglandins, and inflammatory cytokines like IL-6 and TNF-α. This mechanism makes NR a genuine mast cell stabilizer rather than just an anti-inflammatory.

For collagen (hEDS): NR activates SIRT1, which blocks the expression of MMP enzymes (collagen-destroying enzymes). It has been shown to reverse MMP-9 upregulation in tenocytes and fibroblasts. Additionally, it upregulates PLOD1 (lysyl hydroxylase), which is required for strong collagen crosslinking.

For mitochondria: NR consistently raises NAD+ levels, which restores mitochondrial function. This is particularly relevant for the multi-system fatigue and cellular dysfunction often seen across the triad.

## Condition-specific notes

### MCAS (Mast Cell Activation Syndrome)

NR is the first NAD+ booster shown to directly stabilize mast cells via the SIRT6 pathway. By reducing Tryptase and Prostaglandin D2 release, it offers a novel mechanism of protection that complements traditional stabilizers like quercetin or luteolin.

### hEDS (hypermobile Ehlers-Danlos Syndrome)

Protects collagen from destruction by inhibiting MMPs and supports the crosslinking process by upregulating PLOD1. For patients with vascular EDS or severe hypermobility, its ability to restore mitochondrial energy in connective tissue cells is a critical benefit.

### POTS (Postural Orthostatic Tachycardia Syndrome)

Supports the vascular system, though caution is needed as it can lower systolic blood pressure by ~10 mmHg. For hyperadrenergic or hypertensive POTS patients, this may be a benefit; for hypotensive patients, it requires careful monitoring of medication efficacy.

## Why this form

**Selected form:** Generic NR chloride (≥99% purity, COA-verified)

Analysis of marketplace NR/NMN products found that ~87% fail their label claims or contain counterfeits. v7.8 spec is generic NR chloride at ≥99% purity with full Certificate of Analysis verification per batch. Most published clinical trials used the branded Niagen form, but the verifiable analytical spec (identity, purity, stability) is what makes the molecule clinically equivalent, not the brand name. NR is chemically synthesized (not fermentation-derived), critical for MCAS patients who must avoid the histamine residues common in bio-derived B-vitamins. BID dosing is essential due to NR's short 2.7-hour half-life.

**Form comparison:**

| Form | Notes | Selected |
|---|---|---|
| Unverified marketplace NR (no COA) | Up to 87% failure rate on label claims; counterfeit risk in untested suppliers | No |
| Generic NR chloride (≥99% purity, COA-verified) | Same molecule used in trials, verified by analytical paperwork; v7.8 spec | Yes |

## Dose protocol

| Step | Dosage | Notes |
|---|---|---|
| Week 1 | 100 mg daily | Assess tolerance (AM only) |
| Week 2 | 125 mg twice daily | Building to target dose |
| Week 3 | 200 mg twice daily | Assessing energy and BP |
| Week 4+ | 250 mg twice daily | Full therapeutic dose (500 mg/day) |

**Timeline to effect:** NAD+ elevation occurs within days. Functional improvements in energy or mast cell symptoms are highly variable and may take 4-12 weeks of consistent Use.

## Evidence summary

### Mast Cell Stabilization (SIRT6 Pathway)

NR directly inhibits the release of standard allergy mediators from human mast cells.

- [1] **Kim et al., "NR suppresses mast cell degranulation via SIRT6".** Design: Preclinical (Theranostics, 2022). Finding: Reduced histamine, tryptase, PGD2, and LTC4 production in human cord blood-derived mast cells.. PMID: 35547746.

### NAD+ Elevation

Consistently doubles or raises NAD+ levels at therapeutic doses.

- [2] **Conze et al., "300 mg → 51% elevation in blood NAD+".** Design: Human RCT (2019). Finding: Dose-dependent and safe NAD+ increases established in multiple human cohorts.. PMID: 31278280.
- [5] **Berven et al., "NR-SAFE trial established safety at 3000 mg/day".** Design: High-dose safety trial (2024). Finding: Demonstrated 5-fold NAD+ increase with no serious adverse events at massive doses.. PMID: 38016950.

### Collagen & Mitochondrial Protection

Protects the extracellular matrix and restores energy production in connective tissue cells.

- [3] **Marcos-Ríos et al., "NR restores mitochondrial function in vEDS cells".** Design: vEDS Cell Model (2025). Finding: Improved mitochondrial health and reduced MMP activity in cells with vascular EDS mutations.. PMID: 40497944.
- [6] **Busch et al., "SIRT1 reverses MMP-9 upregulation in tenocytes".** Finding: Activation of sirtuin pathways directly opposes the 'broken bucket' mechanism of collagen breakdown.. PMID: 22689577.

## Evidence gaps

No clinical trials currently exist specifically in hEDS, POTS, or MCAS populations. While NR robustly elevates NAD+ (a biomarker), functional clinical outcomes in humans have been mixed in other populations. The mast cell stabilization property is currently supported by high-quality preclinical/lab data but requires MCAS patient validation.

## Safety

**Side effects:** NR shows excellent safety even at extremely high doses (up to 3,000 mg). Occasional mild effects (<10%) include nausea, bloating, fatigue, or mild headaches. Long-term safety has been established in multi-month trials.

**Interactions:** Blood pressure medications: Additive hypotension (~10 mmHg). Beta-blockers/Midodrine: May have opposing or additive effects on orthostatic symptoms. Warfarin: Monitor INR periodically. Diabetes medications: May affect glucose sensitivity.

**Cautions:** A 10 mmHg systolic blood pressure reduction is documented. Patients on fludrocortisone or midodrine should monitor for reduced medication efficacy. Patients with methylation issues may benefit from concurrent methyl-donors (B12/Folate).

**Excipients to avoid:** Fermentation-derived B-vitamins, Unverified marketplace fillers

**Excipients that are safe:** Generic NR chloride (≥99% purity, COA-verified, fermentation-free), Methylation support if needed

## Frequently asked questions

### Does NR actually raise NAD+?

In blood, yes - consistently. Multiple human trials show 50-100% increases in whole-blood NAD+ at 250-1,000 mg/day. In skeletal muscle, the picture is murkier; one well-run trial found no muscle NAD+ increase at high doses. Different tissues handle NAD+ precursors differently, and the mast cell relevance runs through immune cells where NR uptake clearly works. For our use case - mast cells and mitochondrial support - the answer is yes.

### Will NR keep me awake at night?

No. The 'NAD+ equals energy' framing is mostly marketing. None of the 35+ human NR trials report stimulation, wakefulness, or sleep disruption. NAD+ isn't a stimulant - it's a cofactor in metabolic reactions that happen 24/7. We split the dose AM and PM out of convention, but the NAD+ pool half-life is about a week, so timing doesn't really matter pharmacologically. Take it whenever fits your routine.

### What about methylation? Doesn't NR use up methyl groups?

Nicotinamide (a downstream metabolite of NR) gets methylated for excretion using the same methyl donors as homocysteine and neurotransmitter metabolism. At 250 mg twice daily, the methyl group draw is real but small. We include methylfolate and methylated B12 in the formulation partly to keep that methyl pool topped up. If you've got known MTHFR variants and significant methylation concerns, mention NR to your prescriber when titrating it in.

### What should I look for in an NR product?

The Certificate of Analysis - that's it. NR is chemically unstable and easy to mishandle, so what you want to see is identity confirmation (it is what it says), purity (≥99% NR Chloride), and stability testing (the batch hasn't degraded to nicotinamide). Anonymous bulk suppliers without testing are genuinely risky for this particular molecule. A reputable generic with full COA verification is functionally equivalent to the named brands at a fraction of the cost.

## References

[1] Kim et al.. (2022). NR suppresses mast cell degranulation via SIRT6. PMID: 35547746. https://pubmed.ncbi.nlm.nih.gov/35547746/
[2] Conze et al.. (2019). Dose-dependent NAD+ increase; 300 mg safe and effective. PMID: 31278280. https://pubmed.ncbi.nlm.nih.gov/31278280/
[3] Marcos-Ríos. (2025). NR restores mitochondrial function in vEDS cells. PMID: 40497944. https://pubmed.ncbi.nlm.nih.gov/40497944/
[4] Martens. (2018). ~10 mmHg BP reduction at 1000 mg/day. PMID: 29599478. https://pubmed.ncbi.nlm.nih.gov/29599478/
[5] Berven. (2024). NR-SAFE: 3000 mg/day safe with 5-fold NAD+ increase. PMID: 38016950. https://pubmed.ncbi.nlm.nih.gov/38016950/
[6] Busch et al., "SIRT1 reverses MMP-9 upregulation in tenocytes". PMID: 22689577. https://pubmed.ncbi.nlm.nih.gov/22689577/